DK2686011T3 - Ipn-vaccine - Google Patents

Ipn-vaccine

Info

Publication number
DK2686011T3
DK2686011T3 DK12725287.2T DK12725287T DK2686011T3 DK 2686011 T3 DK2686011 T3 DK 2686011T3 DK 12725287 T DK12725287 T DK 12725287T DK 2686011 T3 DK2686011 T3 DK 2686011T3
Authority
DK
Denmark
Prior art keywords
ipn vaccine
ipn
vaccine
Prior art date
Application number
DK12725287.2T
Other languages
English (en)
Inventor
Stephen Mutoloki
Øystein Evensen
Trude Bakke Jøssund
Gordon Ritchie
Original Assignee
Benchmark Animal Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benchmark Animal Health Ltd filed Critical Benchmark Animal Health Ltd
Application granted granted Critical
Publication of DK2686011T3 publication Critical patent/DK2686011T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK12725287.2T 2011-03-16 2012-03-14 Ipn-vaccine DK2686011T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20110402 2011-03-16
NO20110650A NO332608B2 (no) 2011-03-16 2011-05-02 Levende avirulent IPNV og vaksine for profylakse eller behandling av IPN-sykdom hos fisk
PCT/NO2012/050040 WO2012078051A2 (en) 2011-03-16 2012-03-14 IPN Vaccine

Publications (1)

Publication Number Publication Date
DK2686011T3 true DK2686011T3 (da) 2017-11-27

Family

ID=46207632

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12725287.2T DK2686011T3 (da) 2011-03-16 2012-03-14 Ipn-vaccine

Country Status (12)

Country Link
US (2) US20140072591A1 (da)
EP (1) EP2686011B8 (da)
JP (1) JP2014513932A (da)
AU (1) AU2012203610A1 (da)
CA (1) CA2830184A1 (da)
CL (1) CL2013002631A1 (da)
DK (1) DK2686011T3 (da)
ES (1) ES2647073T3 (da)
NO (2) NO332608B2 (da)
PT (1) PT2686011T (da)
RU (1) RU2013146020A (da)
WO (1) WO2012078051A2 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201400311D0 (en) * 2014-01-08 2014-02-26 Aqua Gen As Treating Susceptibility
WO2016005796A1 (en) * 2014-07-11 2016-01-14 Fundacion Fraunhofer Chile Research Agent with antiviral properties for preventing or treating individuals exposed to a virus of the birnaviridae family
GB2533618B (en) * 2014-12-23 2019-11-13 The Marine Biological Ass Of The United Kingdom Type B DWV for use in superinfection exclusion protection of Apis mellifera against Type A DWV
GB201505310D0 (en) 2015-03-27 2015-05-13 Fvg Ltd IPN virus genome mutations and codon interactions
BR112018015527A2 (pt) 2016-02-02 2018-12-26 Benchmark Animal Health Ltd métodos para produção de vírus
WO2023160425A1 (zh) * 2022-02-24 2023-08-31 中国水产科学研究院黑龙江水产研究所 一种鲑鳟鱼传染性造血器官坏死病和传染性胰脏坏死病单价佐剂疫苗及其二联佐剂疫苗和制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999050419A2 (en) * 1998-03-31 1999-10-07 University Of Maryland Biotechnology Institute A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts

Also Published As

Publication number Publication date
CL2013002631A1 (es) 2014-07-25
WO2012078051A3 (en) 2012-12-27
PT2686011T (pt) 2017-11-23
EP2686011B8 (en) 2017-10-04
JP2014513932A (ja) 2014-06-19
RU2013146020A (ru) 2015-04-27
EP2686011B1 (en) 2017-08-30
WO2012078051A2 (en) 2012-06-14
EP2686011A2 (en) 2014-01-22
ES2647073T3 (es) 2017-12-19
AU2012203610A1 (en) 2013-10-17
US20160122728A1 (en) 2016-05-05
CA2830184A1 (en) 2012-06-14
NO2686011T3 (da) 2018-01-27
NO332608B1 (no) 2012-11-19
US20140072591A1 (en) 2014-03-13
NO20110650A1 (no) 2012-09-17
NZ615974A (en) 2015-09-25
NO332608B2 (no) 2012-11-19

Similar Documents

Publication Publication Date Title
NO2025028I1 (no) Evinacumab - forlenget
NO2021029I1 (no) tukatinib
NO2021053I1 (no) bimekizumab
EP2715659A4 (en) ABOUT FEED
DK2769050T3 (da) Propsensor
DE102011100082A8 (de) Traygreifvorrichtung
EP2795884A4 (en) Audio conferencing
BR112014000879A2 (pt) deflegmador
DK3272861T3 (da) Alpha-galactosidase-sammensætninger
EP2701512A4 (en) Aldosterone synthase inhibitors
BR112014005756A2 (pt) vacina
CO6960543A2 (es) 2-tiopirimidinonas
EP2723481A4 (en) FLOW COMPENSATOR
DK3141251T3 (da) Koloskopi - forberedelse
EP2708561A4 (en) BIO-PIN
EP2695208A4 (en) MICRO THERMOCOUPLE
EP2715068A4 (en) Tunneling apparatus
EP2738148A4 (en) RECIPROCAL LOCKING BLOCK
DE112011104936A5 (de) Stanzstauchniet
EP2763699A4 (en) VACCINE
DK2748612T3 (da) Forbedret vaccinediagnostik
PT2686011T (pt) Vacina contra npi
DE112012000958A5 (de) Handsäge
FR2972921B1 (fr) Sucette orthodontique
EP2729467A4 (en) CRYPTATE COMPOUNDS